ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD03.59

D03.59

Billable

Melanoma in situ of other part of trunk

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D03.59 is a billable code used to indicate a diagnosis of melanoma in situ of other part of trunk.

Key Diagnostic Point:

Melanoma in situ is a type of skin cancer that is confined to the epidermis, the outermost layer of skin, and has not invaded deeper tissues. The term 'in situ' indicates that the cancerous cells are localized and have not spread to surrounding tissues. This specific code, D03.59, refers to melanoma in situ located in areas of the trunk that are not otherwise specified, such as the back, abdomen, or chest. Melanoma in situ is characterized by the presence of atypical melanocytes that can be identified through histopathological examination. Early detection and treatment are crucial, as melanoma in situ has a high cure rate when treated promptly. Surveillance protocols typically involve regular skin examinations and monitoring for any changes in existing lesions or the appearance of new lesions. The risk of progression to invasive melanoma is a significant concern, particularly if the in situ melanoma is not adequately managed. Factors such as the size, location, and histological features of the melanoma can influence the likelihood of progression, necessitating careful follow-up and patient education regarding self-examination and sun protection measures.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between in situ and invasive melanoma
  • Identifying the specific location on the trunk
  • Understanding the nuances of melanoma staging
  • Documentation of biopsy results and pathology reports

Audit Risk Factors

  • Inadequate documentation of biopsy results
  • Failure to specify the exact location of the melanoma
  • Lack of follow-up documentation for surveillance
  • Misclassification of in situ versus invasive melanoma

Specialty Focus

Medical Specialties

Dermatology

Documentation Requirements

Complete pathology reports, detailed descriptions of lesions, and treatment plans.

Common Clinical Scenarios

Skin examinations, biopsies of suspicious lesions, and follow-up visits for melanoma management.

Billing Considerations

Ensure accurate documentation of lesion characteristics and patient history to support coding.

Oncology

Documentation Requirements

Comprehensive treatment plans, staging information, and follow-up care documentation.

Common Clinical Scenarios

Management of melanoma treatment, including surgical excision and adjuvant therapies.

Billing Considerations

Documenting the rationale for treatment decisions and monitoring for recurrence.

Coding Guidelines

Inclusion Criteria

Use D03.59 When
  • According to ICD
  • CM guidelines, D03
  • 59 should be used when the melanoma is confirmed as in situ and located in an unspecified area of the trunk
  • Coders must ensure that the diagnosis is supported by pathology reports and that the location is clearly documented

Exclusion Criteria

Do NOT use D03.59 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

11600CPT Code

Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter over 4.0 cm

Clinical Scenario

Used when excising a melanoma in situ from the trunk.

Documentation Requirements

Pathology report confirming melanoma in situ and excision notes.

Specialty Considerations

Dermatologists must ensure clear documentation of the lesion's characteristics.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of melanoma in situ, improving the accuracy of data collection and enhancing the ability to track treatment outcomes and resource utilization.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of melanoma in situ, improving the accuracy of data collection and enhancing the ability to track treatment outcomes and resource utilization.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of melanoma in situ, improving the accuracy of data collection and enhancing the ability to track treatment outcomes and resource utilization.

Resources

Clinical References

  • •
    American Academy of Dermatology

Coding & Billing References

  • •
    American Academy of Dermatology

Frequently Asked Questions

What is the difference between melanoma in situ and invasive melanoma?

Melanoma in situ is confined to the epidermis and has not invaded deeper tissues, while invasive melanoma has penetrated beyond the epidermis into the dermis or deeper layers.